Fosun International LTD Revance Therapeutics, Inc. Transaction History

Fosun International LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$26.8 - $31.84 $6.27 Million - $7.45 Million	-233,841 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$23.23 - $34.3 $4.88 Million - $7.2 Million	-210,000 Reduced 47.31%	233,841 $5.88 Million
Q2 2020 Aug 12, 2020	SELL	$12.6 - $26.55 $321,186 - $676,786	-25,491 Reduced 5.43%	443,841 $10.8 Million
Q1 2020 May 11, 2020	SELL	$12.46 - $27.81 $39,872 - $88,992	-3,200 Reduced 0.68%	469,332 $6.95 Million
Q2 2018 Aug 13, 2018	BUY	$27.45 - $33.35 $4.21 Million - $5.11 Million	153,219 Added 47.98%	472,532 $13 Million
Q1 2018 May 08, 2018	BUY	$29.15 - $37.4 $9.31 Million - $11.9 Million	319,313 New	319,313 $9.84 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.